Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Collins

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Plos One|May 25, 2019
Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patientsMichelle Rath, Qiyuan Li, Huili Li, et al.
Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2020
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer RiskKevin H Kensler, Emily Z F Liu, Suzanne C Wetstein, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarityFresia Pareja, Edaise M da Silva, Denise Frosina, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
JNCI Cancer Spectrum|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohortStefania Morganti, Se E Kim, Qingchun Jin, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Plos One|May 25, 2019
Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patientsMichelle Rath, Qiyuan Li, Huili Li, et al.
Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2020
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer RiskKevin H Kensler, Emily Z F Liu, Suzanne C Wetstein, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarityFresia Pareja, Edaise M da Silva, Denise Frosina, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
JNCI Cancer Spectrum|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohortStefania Morganti, Se E Kim, Qingchun Jin, et al.
Pageof 15